2025 annual financial data

Adaptive Biotechnologies 2025 Financial results

Direct answer

Revenue was 276,976,000 USD.

Operating income was -57,123,000 USD and net income was -59,499,000 USD.
Operating cash flow was -45,986,000 USD.

Get free Adaptive Biotechnologies email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
276,976,000 USD
Operating income
-57,123,000 USD
Net income
-59,499,000 USD
Operating cash flow
-45,986,000 USD